Join the club for FREE to access the whole archive and other member benefits.

Altos Labs

Biotechnology company focused on cellular rejuvenation programming

Altos is dedicated to unraveling the deep biology of cellular rejuvenation programming. Our mission is to restore cell health and resilience to reverse disease, injury, and disabilities that occur throughout life.   

The Altos Institutes of Science will pursue deep scientific questions and integrate their findings into one collaborative research effort. The Altos Institute of Medicine will capture knowledge generated about cell health and programming and develop transformative medicines.

Visit website: https://altoslabs.com/

 altoslabs

 altos_labs

People at Altos Labs

Morgan Levine

Founding Principal Investigator at Altos labs, Authored True Age book

Ken Raj

Principal Investigator of the San Diego Institute of Science at Altos Labs

Martin Denzel

Principal Investigator at AltosLabs and researcher at Max Planck Institute for Biology of Ageing

Hal Barron

President Research And Development at GSK, former president of research and development at Calico and incoming CEO at Altos Labs

Rick Klausner

Chief Scientist and Founder at Altos Labs

Altos Labs News

Umbilical cord blood derived plasma improves health biomarkers

Lifespan.io (LEAF) - 06-Sep-2022

Plasma concentrate alters methylation clock reducing biological age

Read more...

Ageing versus longevity: epigenetic age correlated with only a few ageing hallmarks

Live Forever Club - 08-Jun-2022

Mitochondrial dysfunction & stem cell exhaustion accelerated the epigenetic clock, but senescent cells & telomere length did not

Read more...

The Observer interviews Morgan Levine about ageing and her move to Altos Labs

The Guardian - 07-May-2022

When it comes to lifespan, you cannot blame 100% on genetics, just 10-30%

Read more...

Long-term partial reprogramming reversed ageing process in mice

The Guardian - 07-Mar-2022

Yamanaka factors restored youthfullness in aged cells, raised hope for new anti-ageing therapies

Read more...

Altos Labs comes out of stealth with $3 billion of capital

Genetic Engineering & Biotechnology News (GEN) - 19-Jan-2022

Huge backing that cellular reprogramming can have a significant impact on health and ageing

Read more...